Show Summary Details
Page of

Colloids in critical illness 

Colloids in critical illness
Chapter:
Colloids in critical illness
Author(s):

Andrew Webb

DOI:
10.1093/med/9780199600830.003.0056
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 29 November 2020

Colloid solutions are homogenous mixtures of large molecules suspended in a crystalloid solution. The efficacy of colloids as volume substitutes or expanders, and length of effect are determined by their physicochemical properties. Smaller volumes of colloid than crystalloid are required for resuscitation. The primary use of colloids is in the correction of circulating volume. Rather than using fixed haemodynamic endpoints, fluid can be given in small aliquots with assessment of the dynamic haemodynamic response to each aliquot. The aim of a fluid challenge is to produce a small, but significant (200 mL) and rapid increase in plasma volume with changes in central venous pressure or stroke volume used to judge fluid responsiveness. Colloid fluids give a reliable increase in plasma volume to judge fluid responsiveness.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.